154 related articles for article (PubMed ID: 38403302)
1. Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Rose AMC; Pozo F; Martínez-Baz I; Mazagatos C; Bossuyt N; Cauchi JP; Petrović G; Loghin II; Vaikutyte R; Buda S; Machado A; Duffy R; Oroszi B; Howard J; Echeverria A; Andreu C; Barbezange C; Džiugytė A; Nonković D; Popescu CP; Majauskaite F; Tolksdorf K; Gomez V; Domegan L; Horváth JK; Castilla J; García M; Demuyser T; Borg ML; Tabain I; Lazar M; Kubiliute I; Dürrwald R; Guiomar R; O'Donnell J; Kristóf K; Nicolay N; Bacci S; Kissling E; ;
Influenza Other Respir Viruses; 2024 Feb; 18(2):e13255. PubMed ID: 38403302
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Maurel M; Pozo F; Pérez-Gimeno G; Buda S; Sève N; Oroszi B; Hooiveld M; Gomez V; Domegan L; Martínez-Baz I; Ilić M; Carnahan AS; Mihai ME; Martínez A; Goerlitz L; Enouf V; Horváth JK; Dijkstra F; Rodrigues AP; Bennett C; Trobajo-Sanmartín C; Mlinarić I; Latorre-Margalef N; Ivanciuc A; Lopez A; Dürrwald R; Falchi A; Túri G; Meijer A; Melo A; O'Donnell J; Castilla J; Vučina VV; Hagey TS; Lazar M; Kaczmarek M; Bacci S; Kissling E;
Influenza Other Respir Viruses; 2024 Jan; 18(1):e13243. PubMed ID: 38204584
[TBL] [Abstract][Full Text] [Related]
3. Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013.
El Omeiri N; Azziz-Baumgartner E; Thompson MG; ; Clará W; Cerpa M; Palekar R; Mirza S; Ropero-Álvarez AM
Vaccine; 2018 Jun; 36(24):3555-3566. PubMed ID: 28648543
[TBL] [Abstract][Full Text] [Related]
4. Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study.
Kissling E; Pozo F; Martínez-Baz I; Buda S; Vilcu AM; Domegan L; Mazagatos C; Dijkstra F; Latorre-Margalef N; Kurečić Filipović S; Machado A; Lazar M; Casado I; Dürrwald R; van der Werf S; O'Donnell J; Linares Dopido JA; Meijer A; Riess M; Višekruna Vučina V; Rodrigues AP; Mihai ME; Castilla J; Goerlitz L; Falchi A; Connell J; Castrillejo D; Hooiveld M; Carnahan A; Ilić M; Guiomar R; Ivanciuc A; Maurel M; Omokanye A; Valenciano M;
Influenza Other Respir Viruses; 2023 Jan; 17(1):e13069. PubMed ID: 36702797
[TBL] [Abstract][Full Text] [Related]
5. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
6. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
[TBL] [Abstract][Full Text] [Related]
7. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
Rondy M; Launay O; Castilla J; Costanzo S; Puig-Barberà J; Gefenaite G; Larrauri A; Rizzo C; Pitigoi D; Syrjänen RK; Machado A; Kurečić Filipović S; Krisztina Horváth J; Paradowska-Stankiewicz I; Marbus S; ; Moren A
Vaccine; 2017 Aug; 35(34):4298-4306. PubMed ID: 28709555
[TBL] [Abstract][Full Text] [Related]
8. Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
Ghamande S; Shaver C; Murthy K; Raiyani C; White HD; Lat T; Arroliga AC; Wyatt D; Talbot HK; Martin ET; Monto AS; Zimmerman RK; Middleton DB; Silveira FP; Ferdinands JM; Patel MM; Gaglani M
Clin Infect Dis; 2022 Apr; 74(8):1329-1337. PubMed ID: 34320171
[TBL] [Abstract][Full Text] [Related]
9. Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.
Rose AMC; Kissling E; Gherasim A; Casado I; Bella A; Launay O; Lazăr M; Marbus S; Kuliese M; Syrjänen R; Machado A; Kurečić Filipović S; Larrauri A; Castilla J; Alfonsi V; Galtier F; Ivanciuc A; Meijer A; Mickiene A; Ikonen N; Gómez V; Lovrić Makarić Z; Moren A; Valenciano M;
Influenza Other Respir Viruses; 2020 May; 14(3):302-310. PubMed ID: 32022450
[TBL] [Abstract][Full Text] [Related]
10. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
[TBL] [Abstract][Full Text] [Related]
11. Estimation of the Effectiveness of Quadrivalent Influenza Vaccines by Distinguishing Between Influenza A (H1N1) pdm09 and Influenza A (H3N2) Using Rapid Influenza Diagnostic Tests During the 2018-2019 Season.
Ando S
Intern Med; 2020 Apr; 59(7):933-940. PubMed ID: 31787695
[TBL] [Abstract][Full Text] [Related]
12. Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.
Andrew MK; Shinde V; Hatchette T; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney J; McGeer A; Nichols MK; Powis J; Richardson D; Semret M; Stiver G; Trottier S; Valiquette L; Webster D; Ye L; McNeil SA;
BMC Infect Dis; 2017 Dec; 17(1):805. PubMed ID: 29284435
[TBL] [Abstract][Full Text] [Related]
13. End-of-season influenza vaccine effectiveness during the Southern Hemisphere 2022 influenza season - Chile, Paraguay, and Uruguay.
Chard AN; Nogareda F; Regan AK; Barraza MFO; Fasce RA; Vergara N; Avendaño M; Penayo E; Vázquez C; Von Horoch M; Michel F; Alfonso A; Mogdasy C; Chiparelli H; Goñi N; Alegretti M; Loayza S; Couto P; Rodriguez A; Salas D; Fowlkes AL; Azziz-Baumgartner E
Int J Infect Dis; 2023 Sep; 134():39-44. PubMed ID: 37201863
[TBL] [Abstract][Full Text] [Related]
14. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.
Kissling E; Valenciano M; Pozo F; Vilcu AM; Reuss A; Rizzo C; Larrauri A; Horváth JK; Brytting M; Domegan L; Korczyńska M; Meijer A; Machado A; Ivanciuc A; Višekruna Vučina V; van der Werf S; Schweiger B; Bella A; Gherasim A; Ferenczi A; Zakikhany K; O Donnell J; Paradowska-Stankiewicz I; Dijkstra F; Guiomar R; Lazar M; Kurečić Filipović S; Johansen K; Moren A;
Influenza Other Respir Viruses; 2018 Jul; 12(4):423-437. PubMed ID: 29125681
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017 - 2018 season.
Bella A; Gesualdo F; Orsi A; Arcuri C; Chironna M; Loconsole D; Napoli C; Orsi GB; Manini I; Montomoli E; Alfonsi V; Castrucci MR; Rizzo C
Expert Rev Vaccines; 2019 Jun; 18(6):671-679. PubMed ID: 31159616
[No Abstract] [Full Text] [Related]
16. Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.
McLean HQ; Caspard H; Griffin MR; Gaglani M; Peters TR; Poehling KA; Ambrose CS; Belongia EA
JAMA Netw Open; 2018 Oct; 1(6):e183742. PubMed ID: 30646262
[TBL] [Abstract][Full Text] [Related]
17. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
[TBL] [Abstract][Full Text] [Related]
18. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
[TBL] [Abstract][Full Text] [Related]
19. Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020.
Tenforde MW; Talbot HK; Trabue CH; Gaglani M; McNeal TM; Monto AS; Martin ET; Zimmerman RK; Silveira FP; Middleton DB; Olson SM; Garten Kondor RJ; Barnes JR; Ferdinands JM; Patel MM;
J Infect Dis; 2021 Sep; 224(5):813-820. PubMed ID: 33378531
[TBL] [Abstract][Full Text] [Related]
20. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
